This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Dsm IP Assets B.v.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Guido Alexander Van Wingen: Innovating Solutions for Addiction Treatment
Introduction: Guido Alexander Van Wingen is a notable inventor based in Nijmegen, Netherlands. With a penchant for creating innovative solutions, he has made significant contributions to the field of medicine, particularly in the treatment of addiction. His singular patent showcases his dedication to helping individuals overcome dependencies through the use of protein hydrolysates.
Latest Patents: Van Wingen holds a patent for "Protein hydrolysates as agents to treat symptoms of addiction." This invention focuses on utilizing a protein hydrolysate, specifically an egg lysozyme hydrolysate, to assist animals, including humans, in overcoming addiction or breaking unwanted habits. This unique approach highlights the potential of dietary interventions in addiction therapy.
Career Highlights: Van Wingen is currently employed at DSM IP Assets B.V., a company known for its commitment to innovation in health and nutrition. His work at this organization involves advancing scientific research and developing products that can improve the quality of life for many individuals.
Collaborations: Throughout his career, Van Wingen has collaborated with esteemed colleagues, including Guillen Santiago Eusebio Fernandez-Reumann and Regina Goralczyk. Together, they have fostered a creative environment that encourages new ideas and breakthroughs in their respective fields.
Conclusion: Guido Alexander Van Wingen is a dedicated inventor whose work is making strides in addiction treatment. Through his patent and collaborative efforts at DSM IP Assets B.V., he exemplifies the impact of innovation in improving human health. His contributions serve as an inspiration for future advancements in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
